Caitong International Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Caitong International Asset Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-53	Closed	-$1.07K	–	3231
2026 Q1	$1.07K	Sell	53 -97	-65%	-$1.56K	﹤0.01%	1418
2025 Q4	$2.42K	Buy	150 +48	+47%	+$636	﹤0.01%	1300
2025 Q3	$1.24K	Buy	+102	New	+$1.41K	﹤0.01%	1436
2025 Q2	–	Sell	-157	Closed	-$1.81K	–	2238
2025 Q1	$1.81K	Hold	157	–	–	﹤0.01%	1390
2024 Q4	$1.33K	Buy	+157	New	+$1.63K	﹤0.01%	1266

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's KALV Position: Q2 2026 in Review

Caitong International Asset Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 53 shares — an estimated $1.07K sold.

Caitong International Asset Management first reported a position in KALV in Q4 2024 and held it in 5 quarters. The position peaked at $2.42K in Q4 2025. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Caitong International Asset Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 53 KalVista Pharmaceuticals shares in Q2 2026, an estimated $1.07K.
Caitong International Asset Management first reported a position in KalVista Pharmaceuticals in Q4 2024 and held it in 5 quarters.
Caitong International Asset Management's KalVista Pharmaceuticals position peaked at $2.42K in Q4 2025.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.